Skip to main content

Table 2 Correlations the clinical characteristics among CNR1 between HCC with or without cirrhosis in TCGA

From: In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC

Variables N Non-cirrhotic HCC N Cirrhotic HCC
CNR1 CNR1
Low/high expression case (n) p value Low/high expression case (n) p value
Gender
 Male 82 44/38 0.282 61 31/30 0.635
 Female 50 22/28 18 8/10
Age at diagnosis
 ≥ 60 80 38/42 0.476 36 17/19 0.650
 < 60 52 28/24 42 22/20
 NA 0 0 1 0/1
T stage
 T1/T2 97 48/49 1.000 70 35/35 0.712
 T3/T4 33 17/16 8 3/5
 TX 1 1/0 0 0/0
 NA 1 0/1 1 1/0
N stage
 N0 91 49/42 0.259 57 29/28 1.000
 N1 1 0/1 1 0/1
 NX 40 17/23 20 10/10
 NA 0 0/0 1 0/1
M stage
 M0 90 46/44 0.529 62 31/31 0.830
 M1 4 3/1 0 0/0
 MX 38 17/21 17 8/9
Pathologic stage
 I/II 91 44/47 0.755 67 35/32 0.478
 III/IV 33 17/16 9 3/6
 NA 8 5/3 3 1/2
Vascular invasion
 None 87 38/49 0.127 52 26/26 0.900
 Micro 33 18/15 22 10/12
 Macro 6 5/1 2 1/1
 NA 6 5/1 3 2/1
HBV infection
 Yes 38 25/13 0.036 36 20/16 0.358
 No 88 40/48 40 18/22
 NA 6 1/5 3 1/2
HCV infection
 Yes 14 6/8 0.488 20 13/7 0.118
 No 112 59/53 56 25/31
 NA 6 1/5 3 1/2
  1. NA not applicable
  2. The significant p value is marked with italic type